mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-06 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |